NORTH CHICAGO, Ill. , Feb. 20, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) will present at the Cowen and Company 33 rd Annual Health Care Conference on Wednesday, March 6 , 2013. Bill Chase , executive vice president and chief financial officer, will make a formal presentation on the company at 7:40
NORTH CHICAGO, Ill. , Feb. 15, 2013 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend and also authorized a share repurchase program of up to $1.5 billion of the Company's outstanding common stock. The cash dividend of $0.40 per share is payable
HUMIRA delivers 9th year of double-digit growth in 2012; forecasting low double-digit growth in 2013 Advances 11 Phase III programs; HCV Phase III trials underway and on track for early 2015 launch Provides full-year 2013 adjusted EPS guidance of $3.03 to $3.13 ($2.66 to $2.76 on a GAAP basis)
- Abbott will host a conference call to discuss Q4 and full-year 2012 business results and 2013 outlook on Jan. 23, 2013 - AbbVie will host a conference call to discuss 2012 business results and 2013 outlook on Jan. 30, 2013 ABBOTT PARK, Ill. and NORTH CHICAGO, Ill. , Jan.
NORTH CHICAGO, Ill. , Jan. 4, 2013 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical company, today declared the Company's first quarterly cash dividend of $0.40 per share. The cash dividend is payable Feb.